The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $481.56, ...

Vertex Pharmaceuticals ( NASDAQ: VRTX) shares fell in premarket trading on Tuesday after the company's VX-993 failed to meet ...

In connection with earnings, Vertex announced topline results from the Phase 2 study evaluating the safety and efficacy of VX ...

Discover how Vertex Pharmaceuticals achieved 12% Q2 2025 revenue growth with new launches like ALYFTREK, CASGEVY, & JOURNAVX.

Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC ...

Talking to "Globes," Oron recalls his first acquaintance with CyberArk’s founders, Udi Mokady (now executive chairperson of ...

Some Boston public school students are spending their summer vacations learning and working at a global biotech company.

Since its debut, Google's AI video generation model, Veo, has shown some incredible potential. That potential is clearly ...

Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any ...

Advanced FloorDetect technology automatically adjusts suction power based on your floor type, and Dirt-Reveal headlights ...